Document is current
Any future updates will be listed below
-
Authors
Cho, Yongtai
Choi, Eun-Young
Han, Jung Yeol
Kim, Hoon
Choe, Young June
Shin, Ju-Young
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (RS-2023-00208978)
- License Information
-
More Information
Article History
Received: 5 June 2025
Accepted: 3 November 2025
First Online: 1 December 2025
Declarations
:
: This study was approved by the Institutional Review Board of Sungkyunkwan University, South Korea (No. 2024-07-035). The requirement for informed consent was waived as the study used de-identified data.
: Not applicable.
: Ju-Young Shin received grants from the Ministry of Food and Drug Safety, the Ministry of Health and Welfare, the National Research Foundation of Korea and pharmaceutical companies, including Pfizer, UCB, and Yuhan, outside the submitted work. Hoon Kim has received honoraria for participation on the advisory board of Bayer, consulting for Merck, LG Chemical and Genome & Company, and lectures for Roche Diagnostics and Organon, which are unrelated to the subjects addressed in this paper. No other relationships or activities have influenced the submitted work.
